netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Results

Looking for Ustekinumab found 13 matches
Open monograph to display formulary status BNF Category
  Ustekinumab Gastro-intestinal system - Interleukin inhibitors - 01.05.03
  Ustekinumab Musculoskeletal and joint diseases - Cytokine modulators - 10.01.03
  Ustekinumab Skin - Drugs affecting the immune response - 13.05.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA: Ustekinumab (Stelara): risk of exfoliative dermatitis (10.01.03)
link in drug section MHRA: Ustekinumab (Stelara): risk of exfoliative dermatitis (13.05.03)
link in drug section NICE TA180: Ustekinumab for the treatment of adults with moderate to severe psoriasis (13.05.03)
link in drug section NICE TA340: Ustekinumab for treating active psoriatic arthritis (10.01.03)
link in drug section NICE TA340: Ustekinumab for treating active psoriatic arthritis (13.05.03)
link in drug section NICE TA455: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA455: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA455: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA456: Ustekinumab for moderately to severely active Crohn’s disease after previous treatment (01.05.03)
link in drug section NICE TA633: Ustekinumab for treating moderately to severely active ulcerative colitis (01.05.03)




Document Library Items Found

 
netFormulary